NASDAQ · IRD
Opus Genetics, Inc.
Smart money pulse
What insiders and funds are doing
- account_balance71 funds bought, 28 sold in the quarter ended Jun 30, 2026. 41 were new holders.
- info5 real insider sales in 12 months. $279K in total, not counting planned sales.
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then. This is data, not advice.
Who owns it
104 funds report owning IRD , up from 79
Last quarter
Who bought and who sold
Change in shares held, biggest funds first. Bars stop at ±100%.
Insider trades · last 12 months
Real buys and sales
Showing 3 real trades. Hidden: 1 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.
Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.
Top holders
Biggest funds in IRD
| Fund | Owns | Value | Change |
|---|---|---|---|
| Caligan Partners LP | — | $25M | +0% |
| Adage Capital Partners Gp, L.l.c. | — | $24.8M | +0% |
| BIOS Capital Management, LP | — | $15.1M | +0% |
| BlackRock, Inc. | — | $12.8M | +2009% |
| Balyasny Asset Management L.P. | — | $12.7M | +14% |
"Owns" is shares reported divided by shares outstanding.